1.276 - 1.300 of 32.813
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Target Corp Call 180,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,06x
- Analysis
- Accenture Call 350,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 11,86x
- Analysis
- Novo Nordisk Call 510,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,89x
- Analysis
- Cisco Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 20,03x
- Analysis
- Accenture Call 250,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,76x
- Analysis
- GE (General Electric) Call 290,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 18,35x
- Analysis
- Amazon.com Call 340,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,97x
- Analysis
- Novo Nordisk Call 270,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,96x
- Analysis
- AT&T Call 29,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 18,05x
- Analysis
- Check Point Call 185,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,84x
- Analysis
- Münchener Rück Call 640,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 20,04x
- Analysis
- Enphase Energy Call 25,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 2,43x
- Analysis
- Novo Nordisk Call 330,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,63x
- Analysis
- Aixtron Call 12,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 5,13x
- Analysis
- Vonovia Call 31,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,85x
- Analysis
- Abbott Call 170,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 13,51x
- Analysis
- Palantir Technologies Call 300,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,44x
- Analysis
- Henkel Vz. Call 100,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 11,01x
- Analysis
- HSBC Call 9,40 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 16,01x
- Analysis
- Amazon.com Call 210,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,65x
- Analysis
- Novo Nordisk Call 285,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,97x
- Analysis
- Allianz Call 370,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,27x
- Analysis
- Novo Nordisk Call 370,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,50x
- Analysis
- Novo Nordisk Call 370,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,04x
- Analysis
- Novo Nordisk Call 390,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,23x
- Analysis